GCC-4001 is under clinical development by Artiva Biotherapeutics and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData, Phase I drugs for Systemic Lupus Erythematosus have ...

Cogent Biosciences shared promising updated results from part 1 of its phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis (SM). The company presented the new ...

Among individuals with advanced systemic mastocytosis (SM), treatment with the selective tyrosine kinase inhibitor bezuclastinib is well tolerated and shows signs of enduring clinical activity, ...

Rosencrance has over 30 years experience as an investigative reporter, writing for many newspapers in… So, what are the most technologically advanced countries in 2025? In this article, we look at 13 ...

The S25 devices are now rumored to come with a very interesting perk: free access to Google's Gemini Advanced. This is the paid subscription version of Google's AI, and it's normally going to cost ...

So long as our institutes of higher learning remain ideological monocultures, they're likely to put ideological interests ahead of their own self-interests You can save this article by registering ...

Google app teardown hints at free Gemini Advanced for the Galaxy S25 series when the phone launches. Different Galaxy S25 models could get varying durations of free access, ranging from three ...

CABA-201 is under clinical development by Cabaletta Bio and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis (Scleroderma) ...

Lotions and sprays can be effective if used properly. However, applying enough spray to all needed areas can be difficult. Ultraviolet (UV) radiation from the sun can cause painful sunburn and lead to ...

This study aims to evaluate the efficacy of Tibulizumab in treating systemic sclerosis (SSc) in adults. Zura Bio, a clinical stage immunology company, is focused on developing novel dual-pathway ...

Zura Bio has initiated the double-blind Phase II TibuSURE trial to assess the humanised tetravalent bispecific dual-antagonist antibody, tibulizumab, in treating systemic sclerosis (SSc), also ...